WAY
WaystarBNasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-22
Current thesis
The cleanest bull read is that Q1 kept growth quality high: revenue grew 22%, subscription revenue outgrew total revenue, EBITDA margin stayed strong, and client metrics remained healthy, which supports a software-compounder framing if AI and Iodine add incremental upsell.
Posture
Constructive
Lead driver
Value
What changed
Next scheduled catalyst: earnings 2026-07-29 · AMC.
What can break
Execution on the Iodine acquisition is still a key swing factor; the company explicitly flags acquisition integration risk in its filings.
Momentum
42
Value
64
Sentiment
69
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $27.00 · Bull $34.00 · Bear $16.00
Earnings
2026-07-29 · AMC
Data freshness
Prices
As of 2026-07-22
Fundamentals
As of 2026-07-22 • Vendor: Data Vendor v1
Scores
As of 2026-07-22 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-05 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-22
Investment thesis
As of 2026-07-22
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $33.74
Why
Momentum42 · Δ7d +30.4
Value64 · Δ7d +1.3
Sentiment69 · Δ7d +2.8
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Value · See fundamentals
Momentum
42
26% active weight
Current posture
7d trendImproving
Δ7d
+30.4
Δ21d
+47.9
Value
64
39% active weight
Current posture
7d trendImproving
Δ7d
+1.3
Δ21d
+0.4
Sentiment
69
34% active weight
Current posture
7d trendImproving
Δ7d
+2.8
Δ21d
-7.1
Why this grade
Composite grade B. Momentum 41.7 / Value 63.7 / Sentiment 68.9
Fundamentals (TTM)As of 2026-07-22
Fundamentals (TTM)
As of 2026-07-22
Market Cap
$3.99B
Beta
-
Shares Out
191.81M
P/E (TTM)
51.4
P/S (TTM)
5.85
P/FCF (TTM)
21.37
Rev YoY
+22.4%
EPS YoY
+36.9%
Gross Margin
+55.9%
Op Margin
+23.4%
Net Debt
$1.39B
Current Ratio
1.76
As of 2026-07-22 • Updated nightlySource: Internal modelMethodology